Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,212.22 +40.07 (+0.49%) Bitcoin USD
58,983.27 +803.96 (+1.38%) CMC Crypto 200
1,276.31 -0.67 (-0.05%)
Twist Bioscience Corporation (TWST)
Pre-market:
| Previous close | 31.96 |
| Open | 32.44 |
| Bid | 31.97 x 200 |
| Ask | 32.08 x 200 |
| Day's range | 30.75 - 32.44 |
| 52-week range | 11.81 - 43.21 |
| Volume | |
| Avg. volume | 871,526 |
| Market cap | 1.851B |
| Beta (5Y monthly) | 1.62 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results
SOUTH SAN FRANCISCO, Calif., May 02, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the second quarter of fiscal 2024 ended March 31, 2024.
- Business Wire
Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
SOUTH SAN FRANCISCO, Calif., April 18, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 second quarter ended March 31, 2024, after market close on Thursday, May 2, 2024. The company plans to hold a conference call and live audio webcast for analysts and investors at 4:30 p.m. Eastern Time to discuss i
- Business Wire
Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations
SOUTH SAN FRANCISCO, Calif., March 28, 2024--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of a new Human Pangenome Spike-in for the Twist Exome 2.0 panel developed to enable researchers to detect a more complete view of genetic variation during whole exome sequencing (WES).
